Filing Flows › Immucell (ICCC) › Net income
Immucell (ICCC) net income by quarter
Immucell's net income was $1.8M in Q2 2026 (second quarter 2026), -6% from Q1 2026. Over the last 5 quarters it ranged from $502K (Q2 2025) to $1.9M (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.8M | -6% | +266% |
| Q1 2026 | $1.9M | +287% | +34% |
| Q2 2025 | $502K | -65% | — |
| Q1 2025 | $1.4M | +181% | — |
| Q4 2024 | $515K | — | — |
Q2 2026 at a glance
Immucell, Q2 2026: revenue $7.2M (+12% year over year), operating margin 26.9%, net earnings $1.8M, operating cash flow $3.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Immucell's net income?
Immucell's net income was $1.8M in Q2 2026 (second quarter 2026), -6% from Q1 2026.
How has Immucell's net income changed?
Over the last 5 quarters it ranged from $502K (Q2 2025) to $1.9M (Q1 2026).